Established and headquartered in Singapore, SCG Cell Therapy Pte Ltd (SCG) is a leading biotechnology company that combines regional advantages in Singapore, China and Germany, to cover the entire value chain from innovative drug research and discovery, manufacturing, clinical development and commercialization. SCG specializes in the development of novel immunotherapies in infections and its associated cancers. The company targets the most common cancer-causing infections: helicobacter pylori, human papillomavirus, and hepatitis B, and develops a broad and unique pipeline of T cell therapies, antibodies, and therapeutic vaccines against infections and to prevent and cure its associated cancers. SCG collaborates with leading scientists and researchers to bring first-in-class medical products/technologies to enhance innovation in medical product development.
| Website | http://www.scgcell.com |
| Revenue | $30.5 million |
| Employees | 19 (16 on RocketReach) |
| Founded | 2017 |
| Phone | +65 6828 7180 |
| Industry | Biotechnology Research |
| Competitors | Novartis, Bristol Myers Squibb, Kite Pharma, CRISPR Therapeutics, bluebird bio, Adaptimmune, CureVac, Sangamo Therapeutics, Inc., Celyad Oncology, OncoSec +33 more (view full list) |
Looking for a particular SCG Cell Therapy employee's phone or email?
SCG Cell Therapy Questions
The SCG Cell Therapy annual revenue was $30.5 million in 2026.
Karin Wisskirchen is the Managing Director - SCG Germany of SCG Cell Therapy.
16 people are employed at SCG Cell Therapy.
Top SCG Cell Therapy Employees
-
2
-
Susanne Wilde
VP, Head of Preclinical Research at SCG Cell Therapy
Germering, BY, DE1 -
Nina Kallin
Group Leader Preclinical Discovery at SCG Cell Therapy
Bavaria, Germany12 -
Ying-Yin Chao
Scientist at SCG Cell Therapy
Munich, BY, DE1 -
1
Related Companies
